Cancer in Primary Immunodeficiency Diseases: An Overlooked Threat
Abstract
No Abstract
1. Fischer A, Notarangelo LD, Casanova JL, de Saint Basile G, Fischer A, Puel A, et al. Primary immunodeficiency diseases: an experimental paradigm for molecular medicine. Front Immunol. 2016;7:365.
2. Mayor PC, Cunningham-Rundles C, Ahmed M, Chinn I, Phelan J, Naqvi N, et al. Cancer risk in primary immunodeficiency diseases: A systematic review and meta-analysis. Front Immunol. 2018;9:3136.
3. Gennery AR, McManus D, Veys P, Patel M, Barnes E, Jones S, et al. Cancer in primary immunodeficiency. Front Pediatr. 2019;7:232.
4. Rezaei N, Sharifi Z, Aghamohammadi A, Karami M, Gharagozlou M, Movahedi M, et al. Cancer occurrence in primary immunodeficiency patients. Curr Opin Allergy Clin Immunol. 2019;19(6):583-90.
5. Gatti RA, Bernatowska-Matuszinska J, Seger R, Puck JM, Vossen J, Rojas-Ochoa A, et al. Immunodeficiency and cancer risk. Nat Rev Immunol. 2017;17(5):329-42.
6. North M, Fisher P, Zhang L, Ochs HD, Cant A, Meyer W, et al. Genetic predisposition to primary immunodeficiency and cancer. Trends Immunol. 2020;41(3):170-80.
7. Dvorak CC, Dorsey M, Guo Y, Goldbach-Mansky R, Tollefson R, Kaufman T, et al. Lymphoma risk in primary immunodeficiency syndromes. Blood Adv. 2020;4(7):1428-45.
8. Booth C, Gracious B, Abolhassani H, Rezaei N, Lankford CS, Barge M, et al. Wiskott-Aldrich syndrome and lymphoid malignancies. Br J Haematol. 2019;184(6):911-22.
9. Derhovanessian E, Ziegler A, Fricke C, Boehm J, Sauter S, Muller L, et al. Ataxia-telangiectasia and cancer susceptibility. Cancer Lett. 2018;420:123-9.
10. Tangye SG, Langenburg S, Burgess J, Manner M, Rao K, Chen K, et al. The importance of patient registries in PID cancer research. Clin Transl Immunol. 2019;8(10):e1093.
11. Patel SY, Pasvol G, Fegan C, Saeed S, Pasvol M, Bhandari R, et al. Education and awareness for PID-related malignancies. J Allergy Clin Immunol. 2020;145(3):765-78.
12. De Miranda NF, Sabin CA, Kiff R, Meyer W, Olds J, Thomas E, et al. Surveillance strategies in PID-associated malignancies. Ann Oncol. 2018;29(4):865-74.
13. Notarangelo LD, Fischer A, Puck JM, Gatti RA, Cunningham-Rundles C, Stiehm ER, et al. Immunodeficiencies and malignancies: a delicate balance. J Clin Invest. 2019;129(1):106-8.
2. Mayor PC, Cunningham-Rundles C, Ahmed M, Chinn I, Phelan J, Naqvi N, et al. Cancer risk in primary immunodeficiency diseases: A systematic review and meta-analysis. Front Immunol. 2018;9:3136.
3. Gennery AR, McManus D, Veys P, Patel M, Barnes E, Jones S, et al. Cancer in primary immunodeficiency. Front Pediatr. 2019;7:232.
4. Rezaei N, Sharifi Z, Aghamohammadi A, Karami M, Gharagozlou M, Movahedi M, et al. Cancer occurrence in primary immunodeficiency patients. Curr Opin Allergy Clin Immunol. 2019;19(6):583-90.
5. Gatti RA, Bernatowska-Matuszinska J, Seger R, Puck JM, Vossen J, Rojas-Ochoa A, et al. Immunodeficiency and cancer risk. Nat Rev Immunol. 2017;17(5):329-42.
6. North M, Fisher P, Zhang L, Ochs HD, Cant A, Meyer W, et al. Genetic predisposition to primary immunodeficiency and cancer. Trends Immunol. 2020;41(3):170-80.
7. Dvorak CC, Dorsey M, Guo Y, Goldbach-Mansky R, Tollefson R, Kaufman T, et al. Lymphoma risk in primary immunodeficiency syndromes. Blood Adv. 2020;4(7):1428-45.
8. Booth C, Gracious B, Abolhassani H, Rezaei N, Lankford CS, Barge M, et al. Wiskott-Aldrich syndrome and lymphoid malignancies. Br J Haematol. 2019;184(6):911-22.
9. Derhovanessian E, Ziegler A, Fricke C, Boehm J, Sauter S, Muller L, et al. Ataxia-telangiectasia and cancer susceptibility. Cancer Lett. 2018;420:123-9.
10. Tangye SG, Langenburg S, Burgess J, Manner M, Rao K, Chen K, et al. The importance of patient registries in PID cancer research. Clin Transl Immunol. 2019;8(10):e1093.
11. Patel SY, Pasvol G, Fegan C, Saeed S, Pasvol M, Bhandari R, et al. Education and awareness for PID-related malignancies. J Allergy Clin Immunol. 2020;145(3):765-78.
12. De Miranda NF, Sabin CA, Kiff R, Meyer W, Olds J, Thomas E, et al. Surveillance strategies in PID-associated malignancies. Ann Oncol. 2018;29(4):865-74.
13. Notarangelo LD, Fischer A, Puck JM, Gatti RA, Cunningham-Rundles C, Stiehm ER, et al. Immunodeficiencies and malignancies: a delicate balance. J Clin Invest. 2019;129(1):106-8.
| Files | ||
| Issue | Vol 8, No 1 (2025) | |
| Section | Editorial | |
| DOI | https://doi.org/10.18502/igj.v8i1.17988 | |
| Keywords | ||
| No Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Mirzaee S. Cancer in Primary Immunodeficiency Diseases: An Overlooked Threat. Immunol Genet J. 2025;8:1-2.
